Affordable Access

Outcome of children with resistant and relapsed Hodgkin's disease.

British Journal of Cancer
Nature Publishing Group
Publication Date
  • Research Article
  • Biology
  • Medicine


During the period 1974-89, 169 children with Hodgkin's disease were treated in the Paediatric Oncology Units of the Royal Marsden and St Bartholomew's Hospitals. The overall actuarial survival for the whole group was 81% at 10 years. Thirty-five of the 169 children either did not achieve a complete remission or subsequently relapsed. The estimated actuarial survival from initial relapse or failure of primary treatment was 60% at 5 years and 45% at 10 years. Over half of the patients requiring salvage therapy had declared themselves within 2 years and only 3 relapses occurred more than 3 years from diagnosis. Very few patients remain disease free long term after failure of primary and initial salvage therapy. Patients relapsing within a year of diagnosis or not achieving a complete response to primary therapy and those with disseminated relapse had a poor response to salvage therapy. A significant subgroup of patients had prolonged survival despite multiple relapses. Neither initial histology nor stage affected survival from relapse although numbers in each subgroup were small.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Outcome of children with resistant and relapsed Ho...

on British Journal of Cancer December 1992

Outcome of children with primary resistant or rela...

on Pediatric Blood & Cancer January 2005

APE chemotherapy for children with relapsed Hodgki...

on Pediatric Blood & Cancer March 2006

[Preliminary outcome for patients with relapsed or...

on Ai zheng = Aizheng = Chinese j... April 2003
More articles like this..